Email Alert | RSS

北京大学学报（医学版） ›› 2021, Vol. 53 ›› Issue (2): 266-272. doi: 10.19723/j.issn.1671-167X.2021.02.006

• 论著 • 上一篇    下一篇

系统性红斑狼疮伴间质性肺炎的临床特点及相关因素分析

夏芳芳1,鲁芙爱1,吕慧敏1,杨国安2,Δ(),刘媛3,Δ()   

  1. 1.风湿免疫科, 内蒙古科技大学包头医学院第一附属医院, 内蒙古自治区包头 014010
    2.中心试验室, 内蒙古科技大学包头医学院第一附属医院, 内蒙古自治区包头 014010
    3.台州市第一人民医院风湿免疫科, 浙江台州 318000
  • 收稿日期:2019-03-24 出版日期:2021-04-18 发布日期:2021-04-21
  • 通讯作者: 杨国安,刘媛 E-mail:0331004@163.com;liuyuanem@163.com
  • 基金资助:
    内蒙古自治区自然科学基金(2017MS(LH)0812);包头医学院科学研究基金(BYJJ-YF 2016100)

Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia

XIA Fang-fang1,LU Fu-ai1,LV Hui-min1,YANG Guo-an2,Δ(),LIU Yuan3,Δ()   

  1. 1. Department of Rheumatology, First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, Inner Mongolia, China
    2. Central Laboratory, First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou 014010, Inner Mongolia, China
    3. Department of Rheumatology, Taizhou First People’s Hospital, Taizhou 318000, Zhejiang, China
  • Received:2019-03-24 Online:2021-04-18 Published:2021-04-21
  • Contact: Guo-an YANG,Yuan LIU E-mail:0331004@163.com;liuyuanem@163.com
  • Supported by:
    Natural Science Foundation of Inner Mongolia(2017MS(LH)0812);Research Funds of Baotou Medical College(BYJJ-YF 2016100)

RICH HTML

   

PDF (PC)

摘要：

目的: 探讨系统性红斑狼疮(systemic lupus erythematosus,SLE)伴间质性肺疾病(interstitial lung disease,ILD)患者的临床特点、影像评分及疾病相关危险因素。方法: 收集2015年1月至2019年3月于包头医学院第一附属医院和台州市第一人民医院风湿免疫科住院且行肺高分辨率计算机断层扫描(high resolution computed tomography,HRCT)检查的60例SLE患者的临床资料,采用1 ∶1配比病例对照研究,两组患者年龄、性别匹配,其中SLE-ILD组的30例为病例组,SLE non-ILD(无ILD)组的30例为对照组。分析SLE-ILD患者的临床特点、影像学特征和肺HRCT评分,并分析SLE-ILD的相关危险因素。结果: 两组相比,胸闷/气短、雷诺现象、Velcro啰音差异有统计学意义(P<0.05);SLE-ILD组比SLE non-ILD组患者的血红蛋白及白蛋白有明显下降趋势,而尿素氮、红细胞沉降率、C反应蛋白、IgG这4个指标有上升趋势,差异有统计学意义(P<0.05);SLE-ILD患者最常见的类型为非特异性间质性肺炎,依次为普通型间质性肺炎和淋巴细胞间质性肺炎;不同ILD分型的临床-影像-生理评分之间比较,差异无统计学意义(P>0.05);不同ILD分型的肺HRCT评分及肺功能之间比较,差异无统计学意义(P>0.05);多因素Logistic回归分析显示,胸闷/气短、白蛋白下降是SLE-ILD发生的危险因素。结论: SLE患者出现胸闷/气短、低白蛋白血症要警惕ILD的发生,非特异性间质性肺炎是SLE-ILD最常见的表现类型。

关键词: 系统性红斑狼疮, 间质性肺疾病, 临床特点, 危险因素

Abstract:

Objective: To investigate the clinical features, radiologic scores and clinically relevant risk factors prognosis of secondary interstitial lung disease (ILD) in patients with systemic lupus erythematosus (SLE). Methods: In this study, 60 SLE patients in Department of Rheumatology of the First Affiliated Hospital of Baotou Medical College and Taizhou First People’s Hospital from January 2015 to March 2019 were retrospectively analyzed. All of those 60 patients with SLE underwent lung high resolution computed tomography (HRCT) examination. We used a 1 ∶1 case-control study. There was a matching of age and gender between the two groups. Thirty patients with SLE related ILD (SLE-ILD) were in the case group, and 30 patients with SLE without ILE (SLE non-ILD) were in the control group. The clinical features, pulmonary function test, radiologic characteristic of SLE patients were collected and were used to analyze SLE-ILD. Results: In this study, we reached the following conclusions: First, there were statistically significant differences in chest tightness/shortness of breath, Raynaud’s phenomenon, and Velcro rale between SLE-ILD and SLE non-ILD patients (both P<0.05); Second, hemoglobin (Hb) and albumin (ALB) in the patients of SLE-ILD had a significant decrease compared with the patients of SLE non-ILD. Blood urea nitrogen (BUN), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) increased in SLE-ILD patients compared with SLE non-ILD patients, the difference had statistical significance (P<0.05); Third, for SLE-ILD patients, the most common type was non-specific interstitial pneumonia (NSIP), followed by usual interstitial pneumonia and lymphocytic interstitial pneumonia; Fourth, there was no significant difference in clinical-radiology-physiology scores between the different ILD types (P>0.05), similarly, the lung HRCT score and lung function between different ILD types had no significant difference (P>0.05); Fifth, multivariate Logistic regression analysis showed that decreased albumin and chest tightness/shortness of breath might be the risk factor for SLE-ILD. Conclusion: There are statistically significant differences between the SLE-ILD group and SLE non-ILD group in terms of chest tightness/shortness of breath, Velcro rale and Raynaud’s phenomenon. Decreased albumin and chest tightness/shortness of breath in SLE patients should be alerted to the occurrence of ILD. NSIP is the most common manifestation of SLE-ILD.

Key words: Systemic lupus erythematosus, Interstitial lung diseases, Clinical features, Risk factors

中图分类号: 

  • R593.24

表1

SLE-ILD与SLE non-ILD患者的临床表现比较"

Clinical
manifestation		 Fever, n (%) Dry cough, n (%) Chest tightness,
n (%)		 Chest pain, n (%) Velcro, n (%) Clubbing, n (%)
Yes No Yes No Yes No Yes No Yes No Yes No
SLE-ILD 16 (53) 14 (47) 9 (30) 21 (70) 22 (73) 8 (27) 2 (6) 28 (94) 18 (60) 12 (40) 3 (10) 27 (90)
SLE non-ILD 14 (47) 16 (53) 9 (30) 21 (70) 12 (40) 18 (60) 3 (10) 27 (90) 10 (33) 20 (67) 1 (3) 29 (97)
χ2 0.267 0.000 6.787 0.000 4.286 0.268
P 0.606 1.000 0.009# >0.999 0.038* 0.605
Clinical
manifestation		 Rash, n (%) Arthritis, n (%) Oral ulcer,
n (%)		 Raynaud’s
phenomenon,
n (%)		 Light allergy,
n (%)		 Myalgia/muscle
weakness, n (%)		 Hair loss,
n (%)
Yes No Yes No Yes No Yes No Yes No Yes No Yes No
SLE-ILD 15 (50) 15 (50) 17 (56) 13 (44) 10 (33) 20 (67) 17 (56) 13 (44) 1 (3) 29 (97) 16 (53) 14 (47) 10 (33) 20 (67)
SLE non-ILD 16 (53) 14 (47) 19 (63) 11 (37) 9 (30) 21 (70) 8 (26) 22 (74) 6 (20) 24 (80) 15 (50) 15 (50) 5 (16) 25 (84)
χ2 0.067 0.278 0.077 5.554 2.588 0.067 2.222
P 0.796 0.598 0.781 0.018* 0.108 0.796 0.136

表2

SLE-ILD与SLE non-ILD患者的实验室检查指标($\bar{x} \pm s$)"

Items SLE-ILD (n=30) SLE non-ILD (n=30) F P
WBC/(×109 cells/L) 6.04±2.04 5.75±1.99 0.305 0.583
Hb/(g/L) 121.73±24.27 135.03±14.25 6.700 0.012*
PLT/(×109 cells/L) 178.23±84.84 194.80±75.36 0.639 0.427
ALT/(U/L) 24.76±20.23 25.06±12.67 0.005 0.944
ALB/(g/L) 38.02±9.83 42.27±4.24 4.726 0.034*
BUN/(mmol/L) 9.90±8.94 6.34±2.91 4.303 0.042*
Scr/(μmol/L) 96.84±58.40 69.70±21.07 5.722 0.020*
C3/(g/L) 0.85±0.28 0.93±0.24 1.301 0.259
C4/(g/L) 0.20±0.09 0.18±0.08 1.674 0.201
IgA/(g/L) 3.03±1.12 3.10±1.23 0.054 0.817
IgM/(g/L) 0.64±0.34 0.75±0.47 1.133 0.292
IgG/(g/L) 14.02±5.24 11.76±2.97 4.219 0.044*

表3

SLE-ILD与SLE non-ILD患者的实验室检查指标[M (P25, P75)]"

Items SLE-ILD SLE non-ILD Statistics P
UTP 0.30 (0.00, 0.97) 0.00 (0.00, 0.21) -0.673 0.501
ESR 55 (15, 114) 8 (7, 15) -10.822 <0.001
CRP 48.80 (12.20, 57.00) 4.18 (3.13, 8.98) -12.427 <0.001

表4

SLE-ILD与SLE non-ILD患者的自身抗体"

Group ANA dsDNA Sm SSA
(Ro-52 kDa)		 SSA
(60 kDa)		 SSB RNP nRNP/Sm
+ - + - + - + - + - + - + - + -
SLE-ILD, n 28 2 16 14 13 17 14 16 15 15 8 22 8 22 15 15
SLE non-ILD, n 26 4 15 15 10 20 9 21 12 18 4 26 13 17 15 15
χ2 0.185 0.067 0.635 0.184 0.436 0.938 1.832 0.000
P 0.667 0.796 0.426 1.763 0.606 0.333 0.176 >0.999

表5

SLE-ILD患者不同ILD分型的临床-影像-生理评分、肺HRCT评分及肺功能比较($\bar{x} \pm s$)"

Items Clinical-radiology-physiology score HRCT score FVC/(%pred) DLCO/(%pred)
UIP 19.29±8.34 2.43±2.15 90.71±25.76 66.71±14.95
NSIP 19.00±12.73 1.00±0.62 69.00±29.70 53.00±39.60
F 0.002 0.748 1.056 0.704
P 0.97 0.42 0.34 0.43

表6

SLE-ILD与SLE non-ILD患者的系统受累表现"

Group Blood system, n (%) Renal system, n (%) Nervous system, n (%) Cardiovascular system, n (%)
Yes No Yes No Yes No Yes No
SLE-ILD 23 (77) 7 (23) 10 (33) 20 (67) 4 (13) 26 (87) 6 (20) 24 (80)
SLE non-ILD 21 (70) 9 (30) 15 (50) 15 (50) 2 (7) 28 (93) 7 (23) 23 (77)
χ2 0.559 0.190 0.667 0.754
P 0.341 1.714 0.185 0.098

表7

SLE-ILD相关危险因素的单因素Logistic回归分析结果"

Items B SE P
Chest tightness 0.339 0.125 0.009
Raynaud’s phenomenon 0.309 0.127 0.018
Velcro 0.268 0.127 0.039
Hb↓ 0.417 0.155 0.009
ALB↓ 0.501 0.156 0.002
BUN↑ 0.278 0.129 0.035
CRP↑ 0.39 0.162 0.019
ESR↑ 0.144 0.135 0.292
IgG -0.032 0.015 0.044

表8

SLE-ILD相关危险因素的多因素Logistic回归分析结果"

Items B SE Wald P OR 95%CI
Chest tightness 1.570 0.624 6.323 0.012 4.808 1.414-16.348
Albumin ↓ 2.848 1.137 6.276 0.012 17.255 1.859-160.185
[1] Weinrib L, Sharma OP, Quismorio FP Jr. A long-term study of interstitial lung disease in systemic lupus erythematosus[J]. Semin Arthritis Rheum, 1990,20(1):48-56.
[2] 陈恒屹, 康军, 崔社怀, 等. 特发性肺间质纤维化合并肺气肿的临床特征分析[J]. 中华肺部疾病杂志:电子版, 2014,7(1):7-11.
[3] Wu XY, Yang M, Xie YS, et al. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort[J]. Clin Rheumatol, 2019,38(1):107-115.
[4] Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus[J]. Arthritis Rheum, 2012,64(8):2677-2686.
pmid: 22553077
[5] Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med, 2013,188(6):733-748.
pmid: 24032382
[6] Gay SE, Kazerooni EA, Toews GB, et al. Idiopathic pulmonary brosis: predictingresponse to therapy and survival[J]. Am J Respir Crit Care Med, 1998,157(4 Pt 1):1063-1072.
pmid: 9563720
[7] Hamblin MJ, Horton MR. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma[J]. Pulm Med, 2011,87(3):87-92.
[8] Gutsche M, Rosen GD, Swigris JJ. Connective tissue disease-associated interstitial lung disease: a review[J]. Curr Respir Care Rep, 2012,1(4):224-232.
[9] 陈晓芳, 杨敏, 赵进军, 等. 系统性红斑狼疮合并间质性肺炎的临床特征及相关危险因素分析[J]. 重庆医学, 2018,47(11):1460-1464.
[10] Mittoo S, Fell CD. Pulmonary manifestations of systemic lupus erythematosus[J]. Semin Respir Crit Care Med, 2014,35(2):249-254.
[11] Aguilera-Pickens G, Abud-Mendoza C. Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage[J]. Reumatol Clin, 2018,14(5):294-300.
pmid: 29773465
[12] Walsh SL, Habsell DM. High-resolution CT of interstitial lung disease: a continuous evolution[J]. Semin Respir Crit Care Med, 2014,35(1):129-144.
pmid: 24481766
[13] Hunninghake GW, Lynch DA, Galvin JR, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia[J]. Chest, 2003,124(4):1215-1223.
pmid: 14555549
[14] Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis[J]. Histopathology, 2004,44(6):585-596.
pmid: 15186274
[15] Palmucci S, Roccasalva F, Puglisi S, et al. Clinical and radiolo-gical features of idiopathic interstitial pneumonias (IIPs): a pictorial review[J]. Insights Imaging, 2014,5(3):347-364.
pmid: 24844883
[16] 李海兰, 熊曾, 刘进康, 等. 结缔组织病相关性肺间质病变的高分辨CT表现[J]. 中南大学学报(医学版), 2017,42(8):934-939.
[17] Oldham JM, Adegunsoye A, Valenzi E, et al. Characterisation of patients with interstitial pneumonia with autoimmune features[J]. Eur Respir J, 2016,47(6):1767-1775.
pmid: 27103387
[18] King TE Jr, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis[J]. N Engl J Med, 2014,370(22):2083-2092.
pmid: 24836312
[19] Wang T, Zheng XJ, Liang BM, et al. Clinical features of rheumatoid arthritis-associated interstitial lung disease[J]. Sci Rep, 2015,5:14897.
pmid: 26443305
[20] Zhang Y, Li H, Wu N, et al. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease[J]. Clin Rheumatol, 2017,36(1):817-823.
[21] Hamblin MJ, Horton MR. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma[J]. Pulm Med, 2011,2011:872120. doi: 10.1155/2011/872120.
doi: 10.1155/2011/872120 pmid: 21660199
[22] Mohammad HA, Hassan AA, Osman N, et al. Detection of pulmonary involvement in lupus patients with and without clinical pulmonary symptoms[J]. Egypt J Chest Dis Tuberc, 2014,63(2):463-469.
[23] 刘媛, 郑毅. BTB-cap'n'collar同源异构体1-siRNA对转化生长因子-β1诱导的小鼠肺成纤维细胞中抗氧化因子表达的影响[J]. 中华风湿病学杂志, 2017,21(4):225-230.
[1] 武志慧, 胡明智, 赵巧英, 吕凤凤, 张晶莹, 张伟, 王永福, 孙晓林, 王慧. miR-125b-5p修饰脐带间充质干细胞对系统性红斑狼疮的免疫调控机制[J]. 北京大学学报（医学版）, 2024, 56(5): 860-867.
[2] 李志存, 吴天俣, 梁磊, 范宇, 孟一森, 张骞. 穿刺活检单针阳性前列腺癌术后病理升级的危险因素分析及列线图模型构建[J]. 北京大学学报（医学版）, 2024, 56(5): 896-901.
[3] 颜野,李小龙,夏海缀,朱学华,张羽婷,张帆,刘可,刘承,马潞林. 前列腺癌根治术后远期膀胱过度活动症的危险因素[J]. 北京大学学报（医学版）, 2024, 56(4): 589-593.
[4] 陈延,李况蒙,洪锴,张树栋,程建星,郑仲杰,唐文豪,赵连明,张海涛,姜辉,林浩成. 阴茎海绵体注射试验对阴茎血管功能影响的回顾性研究[J]. 北京大学学报（医学版）, 2024, 56(4): 680-686.
[5] 庞博,郭桐君,陈曦,郭华棋,石嘉章,陈娟,王欣梅,李耀妍,单安琪,余恒意,黄婧,汤乃军,王艳,郭新彪,李国星,吴少伟. 天津与上海35岁以上人群氮氧化物个体暴露水平及其影响因素[J]. 北京大学学报（医学版）, 2024, 56(4): 700-707.
[6] 和静,房中则,杨颖,刘静,马文瑶,霍勇,高炜,武阳丰,谢高强. 血浆中脂质代谢分子与颈动脉粥样硬化斑块、传统心血管危险因素及膳食因素的关系[J]. 北京大学学报（医学版）, 2024, 56(4): 722-728.
[7] 乔佳佳,田聪,黄晓波,刘军. 肾结石合并系统性红斑狼疮行经皮肾镜碎石取石术的安全性和有效性评估[J]. 北京大学学报（医学版）, 2024, 56(4): 745-749.
[8] 蔡珊,张依航,陈子玥,刘云飞,党佳佳,师嫡,李佳欣,黄天彧,马军,宋逸. 北京市中小学生身体活动时间现状及影响因素的路径[J]. 北京大学学报（医学版）, 2024, 56(3): 403-410.
[9] 张祖洪,陈天娇,马军. 中小学生青春发动时相与心血管代谢危险因素的相关性[J]. 北京大学学报（医学版）, 2024, 56(3): 418-423.
[10] 林郁婷,王华丽,田宇,巩俐彤,常春. 北京市老年人认知功能的影响因素[J]. 北京大学学报（医学版）, 2024, 56(3): 456-461.
[11] 朱金荣,赵亚娜,黄巍,赵微微,王悦,王松,苏春燕. 感染新型冠状病毒的血液透析患者的临床特征[J]. 北京大学学报（医学版）, 2024, 56(2): 267-272.
[12] 任立敏,赵楚楚,赵义,周惠琼,张莉芸,王友莲,沈凌汛,范文强,李洋,厉小梅,王吉波,程永静,彭嘉婧,赵晓珍,邵苗,李茹. 系统性红斑狼疮低疾病活动度及缓解状况的真实世界研究[J]. 北京大学学报（医学版）, 2024, 56(2): 273-278.
[13] 赖展鸿,李嘉辰,贠泽霖,张永刚,张昊,邢晓燕,邵苗,金月波,王乃迪,李依敏,李玉慧,栗占国. 特发性炎性肌病完全临床应答相关因素的单中心真实世界研究[J]. 北京大学学报（医学版）, 2024, 56(2): 284-292.
[14] 司筱芊,赵秀娟,朱凤雪,王天兵. 创伤出血性休克后急性呼吸窘迫综合征的危险因素[J]. 北京大学学报（医学版）, 2024, 56(2): 307-312.
[15] 李洋洋,侯林,马紫君,黄山雅美,刘捷,曾超美,秦炯. 孕期因素与婴儿牛奶蛋白过敏的关系[J]. 北京大学学报（医学版）, 2024, 56(1): 144-149.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部